Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Anisodine Hydrobromide in Patients With Ischemic Stroke Undergoing Endovascular Treatment

NCT07800572 is registered in ClinicalTrials.gov with Capital Medical University as lead sponsor.

NCT NCT07800572
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07800572 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Anisodine Hydrobromide in Patients With Ischemic Stroke Undergoing Endovascular Treatment
Lead sponsor
Capital Medical University
Phase
Phase 2
Overall status
Recruiting
Start date
September 6, 2026
Completion date
March 31, 2027
Enrollment
204 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke